Keloid microRNA expression analysis and the influence of miR-199a-5p on the proliferation of keloid fibroblasts

Genetics and Molecular Research

Volumn 13, Issue 2, 2014, Pages 2727-2738

  Wu, Z Y ^a   Lu, L ^b   Liang, J ^a   Guo, X R ^c   Zhang, P H ^a   Luo, S J ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

^c Plastic Surgery Laser Center The Second People's Hospital of Zhongshan City   (China)

Author keywords

Expression profile; Keloid; Keloid fibroblast; KF proliferation; MiR 199a 5p

Indexed keywords

MICRORNA; MICRORNA 199A 5P; UNCLASSIFIED DRUG; MIRN199 MICRORNA, HUMAN;

ADULT; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KELOID; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA HYBRIDIZATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM;

CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KELOID; MICROARRAY ANALYSIS; MICRORNAS; TRANSFECTION;

EID: 84899144021     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.April.14.2     Document Type: Article

References (27)

1. Abergel RP, Pizzurro D, Meeker CA, Lask G, et al. (1985). Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J. Invest. Dermatol. 84: 384-390.
2. Akasaka Y, Ito K, Fujita K, Komiyama K, et al. (2005). Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen. 13: 373-382.
3. Bentwich I, Avniel A, Karov Y, Aharonov R, et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37: 766-770.
4. Calin GA, Dumitru CD, Shimizu M, Bichi R, et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99: 15524-15529.
5. Calin GA, Sevignani C, Dumitru CD, Hyslop T, et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101: 2999-3004.
6. Carthew RW (2006). Gene regulation by microRNAs. Curr. Opin. Genet. Dev. 16: 203-208.
7. Chan JA, Krichevsky AM and Kosik KS (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65: 6029-6033.
8. Cheung HH, Davis AJ, Lee TL, Pang AL, et al. (2011). Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30: 3404-3415.
9. Cho WC (2007). OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Canc. 6: 60.
10. Cimmino A, Calin GA, Fabbri M, Iorio MV, et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 102: 13944-13949.
11. Fang J, Song XW, Tian J, Chen HY, et al. (2012). Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17: 410-423.
12. Huang G, Nishimoto K, Zhou Z, Hughes D, et al. (2012). miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res. 72: 908-916.
13. Iorio MV, Ferracin M, Liu CG, Veronese A, et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65: 7065-7070.
14. Liu Y, Gao J, Liu X, Lu F, et al. (2008). Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22: 1433-1436.
15. Lu F and Gao J (2005). Experimental gene therapy of keloid in vitro using recombinant adenovirus coding for Fas gene. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19: 35-38.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
17. Lu M, Zhang Q, Deng M, Miao J, et al. (2008). An analysis of human microRNA and disease associations. PLoS One 3: e3420.
18. Mota M, Reeder M, Chernoff J and Bazenet CE (2001). Evidence for a role of mixed lineage kinases in neuronal apoptosis. J. Neurosci. 21: 4949-4957.
19. Murakami Y, Yasuda T, Saigo K, Urashima T, et al. (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25: 2537-2545.
20. Murakami Y, Toyoda H, Tanaka M, Kuroda M, et al. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One 6: e16081.
21. Ohtsuru A, Yoshimoto H, Ishihara H, Namba H, et al. (2000). Insulin-like growth factor-I (IGF-I)/IGF-I receptor axis and increased invasion activity of fibroblasts in keloid. Endocr. J. 47 (Suppl): S41-S44.
22. Rane S, He M, Sayed D, Yan L, et al. (2010). An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p. Cell Signal. 22: 1054-1062.
23. Saed GM, Ladin D, Olson J, Han X, et al. (1998). Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch. Dermatol. 134: 963-967.
24. Satish L, Lyons-Weiler J, Hebda PA and Wells A (2006). Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen. 14: 463-470.
25. Shen Q, Cicinnati VR, Zhang X, Iacob S, et al. (2010). Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol. Cancer 9: 227.
26. Song G, Zeng H, Li J, Xiao L, et al. (2010). miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer. Biol. Pharm. Bull. 33: 1822-1827.
27. Teofoli P, Barduagni S, Ribuffo M, Campanella A, et al. (1999). Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J. Dermatol. Sci. 22: 31-37.